Footnotes

Footnotes:

1  Reardon, D. (2000).  Abortion and subsequent substance abuse.  The American Journal of Drug and Alcohol Abuse 26 (1), pp. 61-75.

2  www.fda.gov website accessed 10/2016

3  Coleman, P., Coyle, C., and Rue, V. (2010). Late-term elective abortion and susceptibility to posttraumatic stress symptoms. Journal of Pregnancy 2010, pp. 1-10

4  Planned Parenthood. (2011). In-clinic abortion procedures:  What happens during an in-clinic abortion?  Retrieved from www.plannedparenthood.org/health-topics 4359.asp

5  American Pregnancy Association. (2007). Types of abortion procedures:  What abortion procedures are used during the first trimester?  Retrieved from www.americanpregnancy.org/unplannedpregnancy

6  Assoc. of Reproductive Health Professionals. (2009). Health matters:  seeking early abortion services.  Retrieved from www.arhp.org/uploaddocs/earlyabortion.

7  American College of Obstetricians and Gynecologists. (2008)  Induced abortion.  Retrieved from www.acog.org/publications.

8  Planned Parenthood. (2011). In-clinic abortion procedures:  What happens during an in-clinic abortion?  Retrieved from www.plannedparenthood.org/health-topics/abortioo 4359.asp

9  Haskel, W., Easterling, T., & Lichtenberg, E. (1999).  Surgical abortion after the first trimester.  In Paul, M., Lichtenberg, E., Borgatta, L., Grimes, D., and Stubblefield, P. (Eds.), A clinician’s guide to medical and surgical abortion.  New York:  Churchill Livingstone.

10  Blumenthal, P., Castleman, L., and Jain, J. (1999).  Abortion by labor induction.  In Paul, M., Lichtenberg, E., Borgatta, L., Grimes D., and Stubblefield, P. (Eds.), A clinician’s guide to medical and surgical abortion.  New York:  Churchill Livingstone.

11  Berek and Novak’s “Gynecology”   14th edition 2007 pg. 300

12  Blumenthal, P., Castleman, L., and Jain, J. (1999).  Abortion by labor induction.  In Paul, M., Lichtenberg, E., Borgatta, L., Grimes D., and Stubblefield, P. (Eds.), A clinician’s guide to medical and surgical abortion.  New York:  Churchill Livingstone.

13  Te Linde’s Operative Gynecology 1992 p. 337

14  http://emedicine.medscape.com/article/795001

Author:  Slava V Gaufberg, MD Assistant Professor of Medicine, Harvard Medical School; Director of Transitional Residency Training Program, Cambridge Health Alliance

Chief Editor:  Pamela L Dyne, MD Professor of Clinical Medicine/Emergency Medicine, University of California, Los Angeles, David Geffen School of Medicine; Attending Physician, Department of Emergency Medicine, Olive View-UCLA Medical Center (accessed 9/2011)

15  www.scdhec.gov (accessed 10/2011)

16  Baggish and Karran “Atlas of Pelvic Anatomy and GYN Surgery” 2011 p. 212.

17  Peter Kovacs, MD, PhD  Medical Director, Clinical Reproductive Endocrinologist, Kaali Institute IVF Center, Budapest, Hungary; Visiting Clinical Instructor, Albert Einstein College of Medicine, Yeshiva University, Bronx, New York; Shah PS, Zao J; Knowledge Synthesis Group of Determinants of preterm/LBW births  BJOG. 2009; 116:1425-1442

18  www.aaplog.org (accessed 11/2011)

19  American Association of Prolife OB/GYNs website at www.aaplog.org (accessed 11/2011)

20  Brind J; (Winter 2005) Induced Abortion as an Independent Risk Factor for Breast Cancer: A Critical Review of Recent Studies Based on Prospective Data J. Amer Physicians & SurgeonsVol10, #4

21  Brind J, (Summer 07) Induced Abortion and Breast Cancer Risk: A Critical Analysis of the Report of the Harvard Nurses Study II; J. Amer P&S; Vol 12, #2

22  Dolle J, Daling J, White E, Brinton L, et al.  Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiol, Biomarkers, Prev 2009; 18 (4) 1157-1166.

23  www.cbsnews.com  Health Pop:   Abortion tied to sharp decline in women’s mental health cites The British Journal of Psychiatry (2011) 199: 180-186 (accessed 11/2011)

24  The Daily Telegraph at www.telegraph.co.uk (accessed 11/2011)

25  The U.S. Food and Drug Administration.  (2016). FDA drug label information:  Mifeprex.  Retrieved from accessdata.fda.gov/drugsatfda_docs/label/2016/020687s013lbl.pdf

26  The U.S. Food and Drug Administration (n.d.).  Medication guide: Mifeprex. Retrieved from http://www.fda.gov/downloads/drugs/drugsafety/USM088643.pdf

27  The U.S. Food and Drug Administration. (2010). FDA drug safety:  Mifeprex questions and answers.  Retrieved from http://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm111328.htm

28  The U.S. Food and Drug Administration (n.d.).  Medication guide:  Mifeprex.  www.fda.gov (accessed 10/2016)

29  www.fda.gov/downloads/drugs/drugsafety  (accessed 10/2016)

30  www.planbonestep.com (accessed 9/2011)

31  www.fda.gov (accessed 9/2015)